![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028年までのアジア太平洋ヘルスケア規制業務アウトソーシング市場予測 - サービスタイプ別の新型コロナウイルス感染症の影響と地域分析(規制および科学戦略開発、医療および科学ライティング、eCTDおよび電子申請、データ管理サービス、ライフサイクル管理サービス、ファーマコビジランス、化学製造および管理 (CMC) サービス、規制ラベル付け、規制アートワーク サービス) およびエンド ユーザー (製薬会社、バイオテクノロジー会社、医療機器会社)
市場紹介
アジア太平洋地域は、中国、日本、インド、オーストラリアと韓国。この市場は、アジア太平洋地域の他の国々でも評価されます。この市場は、アウトソーシングの比較的低コスト、技術的専門知識を備えた熟練した労働力、インドや中国などの国々でのヘルスケア企業の拡大などの要因によって牽引されています。さらに、臨床試験の数の増加と、インド、東南アジア、中国などの新興経済国の市場に参入しようとする企業の数の増加が、予測期間中の医療規制事務アウトソーシング市場の成長に寄与すると予想されます。日本の医薬品市場は飛躍的に成長しています。日本の高齢化人口の増加に対応するため、政府は規制政策を緩和し、それによって新薬の開発と市場への承認を加速することに重点を置いています。これにより、既存の世界的製薬企業と新規参入企業が日本に市場を確立するよう誘致されることが期待されています。これに伴い、サービス型の開発から事業化段階までを必要とする各種規制アウトソーシングサービスの需要の増加が見込まれます。コストを削減し、サービスタイプのスケジュールを合理化するために、企業は規制および医薬品監視活動を業界にアウトソーシングすることに主に焦点を当てています。これにより、この国の医療規制事務アウトソーシング市場の成長が促進されると予想されます。特殊療法、希少疾病用医薬品、個別化医療の進歩は、アジア太平洋地域の医療規制業務アウトソーシング市場の成長を促進する主な要因です。
良好な供給市場により、強力な存在感を示しています。製薬会社は、アジア太平洋地域が臨床試験を実施するのに魅力的な市場であると認識しています。しかし、新型コロナウイルス感染症のパンデミックは世界中に前例のない課題をもたらしています。新型コロナウイルス感染症(COVID-19)の臨床・規制業務、製造・サプライチェーン、利害関係者の関与への影響により、成長を続ける製薬業界のペースが鈍化しています。オーストラリアは、厳格な検疫システムと高度な接触者追跡による新型コロナウイルス感染症の蔓延管理策で世界的に高く評価されている。しかし、参加者が感染を恐れて診療所や病院に通うことに消極的だったため、一部の施設では患者やボランティアの臨床試験への参加が減少した。このように、パンデミックの状況により、臨床試験の停止、製品承認の遅れ、サプライチェーンの混乱が生じています。パンデミックにより、製薬会社と規制当局は、さまざまな機能領域にわたって観察される課題を軽減するための革新的な戦略の採用を余儀なくされました。新型コロナウイルス感染症の影響により、トラベルバーによる現地検査の遅れや、いくつかの製品の承認の遅れが発生しております。これにより、製薬活動の約 65% が CRO にアウトソーシングされ、将来的にはその数が 75% に達すると予想されています。これに加えて、革新的な医薬品の需要により、製薬会社は営業コストを変えずに新製品を提供するために研究開発費を増やすというプレッシャーにさらされています。こうした状況は、医師が効率的な方法で患者を遠隔監視できるようにするデジタル プラットフォームへの投資も引き起こしました。これらすべての要因は、アジア太平洋地域の医療規制業務アウトソーシング ビジネスに影響を及ぼします。
市場の概要とダイナミクス
APAC の医療規制業務アウトソーシング市場は、2021 年の 12 億 397 万米ドルから 2028 年までに 25 億 8,687 万米ドルに成長すると予想されています。 2021 年から 2028 年にかけて 11.5% の CAGR で成長すると推定されています。医療規制関連業界は、数百の中小規模のサービス限定プロバイダーと、少数の大規模なフルサービスの多国籍 CRO が存在し、非常に細分化されています。 。小規模な CRO が医療規制業務のアウトソーシング市場に参入するにはいくつかの障壁に直面しますが、地域に拠点を置くフルサービスの CRO は、多数の国にわたる複数の複雑な規制サービスを同時に管理できる機能を備えた必要なインフラストラクチャを構築する必要があります。後者は、戦略的パートナーと必要な関係を構築し、関連する治療法を開発し、クライアントのニーズに応える専門知識を開発する必要もあります。規制関連業界全体の統合は新たなトレンドであり、主要企業が自社のサービス提供を強化し、市場で主要なシェアを獲得するのに役立ちます。しかし、これにより、幅広い範囲、広範な治療および開発の専門知識、莫大な資本、技術リソースを備えた少数の大規模 CRO が誕生し、製薬会社やバイオ医薬品会社の要求の厳しい医薬品開発プログラムを管理することが可能になりました。
主要市場セグメント
APACの医療規制業務アウトソーシング市場は、サービスの種類、エンドユーザー、国に基づいてセグメント化されています。サービスの種類に基づいて、APACの医療規制事務アウトソーシング市場は医療と医療に分類されます。科学論文、ファーマコビジランス、データ管理サービス、ライフサイクル管理サービス、eCTD および電子申請、規制および科学戦略の開発、化学製造および管理 (CMC) サービス、規制ラベル、および規制アートワーク サービス。医療と医療2020年は科学執筆セグメントが市場を支配しており、ファーマコビジランスセグメントは予測期間中に最も急速に成長すると予想されています。エンドユーザーに基づいて、市場は製薬会社、バイオテクノロジー会社、医療機器会社に分類されます。製薬会社セグメントは 2020 年の市場を支配しており、予測期間中に最も急速に成長すると予想されています。同様に、医療機器企業は医療機器材料と医療機器に分類されます。生体材料、医療機器、バイオマーカーおよび体外診断 (IVD)、医療機器ソフトウェア (SaMD)、医療機器電気機械学、医療機器物質ベース、および複合製品の医療機器。
< scan>リストされている主要な情報源と企業
ヘルスケアに関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源APAC の規制業務アウトソーシング市場には、企業の Web サイト、年次報告書、財務報告書、国家政府の文書、統計データベースなどが含まれます。レポートに記載されている主要企業は、Arriello Ireland Ltd.、Azierta Contract Science Support Consulting、IQVIA Inc.、PAREXEL INTERNATIONAL CORPORATION、PHARMALEX GMBH、ProductLife Group、ProPharma Group、および Voisin Consulting Life Sciences (VCLS) などです。
購入理由レポート
- APAC の医療規制業務アウトソーシング市場の状況を理解し、高い収益を保証する可能性が最も高い市場セグメントを特定する
- APAC の医療規制業務アウトソーシング市場の絶え間なく変化する競争環境を理解し、競争に先んじる
- APAC の医療規制業務における M&A や提携取引を効率的に計画する最も売上が見込める市場セグメントを特定することにより、事務アウトソーシング市場を分析する
- アジア太平洋地域の医療規制事務アウトソーシングのさまざまなセグメントの市場パフォーマンスを知覚的かつ包括的に分析することで、知識に基づいたビジネス上の意思決定を行うのに役立ちます。市場
- APAC 地域の 2021 年から 2028 年までのさまざまなセグメントごとの市場収益予測を取得します。
APAC ヘルスケアの規制問題アウトソーシング市場セグメンテーション
APAC ヘルスケア薬事アウトソーシング市場 – サービス タイプ別
- 医療および;科学論文
- ファーマコビジランス
- データ管理サービス
- ライフサイクル管理サービス
- eCTD および電子申請
- 規制および科学戦略の策定
- 化学製造および管理 (CMC) サービス
- 規制ラベル
- 規制アートワーク サービス
アジア太平洋地域のヘルスケア規制業務アウトソーシング市場 –エンドユーザー別
- 製薬会社
- バイオテクノロジー企業
- 医療機器会社
- 医療機器材料および医療機器材料生体材料
- 医療機器バイオマーカーおよび体外診断 (IVD)
- 医療機器ソフトウェア (SaMD)
- 医療機器電気機械
- 物質ベースの医療機器
- 複合製品の医療機器
アジア太平洋地域のヘルスケア規制業務アウトソーシング市場 – 国別
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- アジア太平洋地域のその他の地域
アジア太平洋地域の医療規制業務アウトソーシング市場 - 会社概要
- Arriello Ireland Ltd.
- Azierta 契約科学サポート コンサルティング
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- >ProductLife グループ
- ProPharma グループ
- Voisin Consulting Life Sciences (VCLS)
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 APAC Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 APAC Healthcare Regulatory Affairs Outsourcing Market – By Country
2. APAC Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.1.1 Asia Pacific– PEST Analysis
4.2 Expert Opinions
5. APAC Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Regulatory Pressure on Healthcare Companies
5.1.2 Escalating Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Surging Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – APAC Analysis
6.1 APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. APAC Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.1.3 China: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.1.3.1 China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.2 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.2.3 Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.2.3.1 Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.3 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.3.3 India: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.3.3.1 India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.4 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.4.3 Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.4.3.1 Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.5 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.5.3 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.5.3.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.6.3.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on APAC Healthcare Regulatory Affairs Outsourcing Market
10.1 Overview
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 ProPharma Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Arriello Ireland Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 PAREXEL INTERNATIONAL CORPORATION
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 IQVIA Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PHARMALEX GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ProductLife Group
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Voisin Consulting Life Sciences (VCLS)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Azierta Contract Science Support Consulting
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 4. China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 8. India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 9. India: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 21. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 22. Glossary of Terms, APAC Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. APAC Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in APAC Healthcare Regulatory Affairs Outsourcing Market
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. Asia pacific PEST Analysis
Figure 7. APAC Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. APAC Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. APAC Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. APAC Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. APAC Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. APAC Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
Figure 31. China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Arriello Ireland Ltd.
- Azierta Contract Science Support Consulting
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma Group
- Voisin Consulting Life Sciences (VCLS)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution